Angelo Martignetti
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer(2001)117 cited
- → Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial(2018)110 cited
- → Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis(2015)105 cited
- → Somatostatin analogs and prednisone in advanced refractory thymic tumors(2002)102 cited
- → Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients(2003)86 cited
- → Art therapy with cancer patients during chemotherapy sessions: An analysis of the patients' perception of helpfulness(2010)75 cited
- → Triple-Negative Breast Cancer: Current State of the Art(2010)71 cited
- → Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer(2017)40 cited
- → First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first‐line treatment for metastatic colorectal cancer(2007)37 cited
- → Cancer patients as `experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)(2000)36 cited